1. Home
  2. PRPO vs SFHG Comparison

PRPO vs SFHG Comparison

Compare PRPO & SFHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRPO
  • SFHG
  • Stock Information
  • Founded
  • PRPO N/A
  • SFHG 1993
  • Country
  • PRPO United States
  • SFHG Hong Kong
  • Employees
  • PRPO N/A
  • SFHG N/A
  • Industry
  • PRPO Biotechnology: Laboratory Analytical Instruments
  • SFHG Publishing
  • Sector
  • PRPO Industrials
  • SFHG Consumer Discretionary
  • Exchange
  • PRPO Nasdaq
  • SFHG Nasdaq
  • Market Cap
  • PRPO 17.1M
  • SFHG 16.6M
  • IPO Year
  • PRPO N/A
  • SFHG 2024
  • Fundamental
  • Price
  • PRPO $14.45
  • SFHG $0.91
  • Analyst Decision
  • PRPO
  • SFHG
  • Analyst Count
  • PRPO 0
  • SFHG 0
  • Target Price
  • PRPO N/A
  • SFHG N/A
  • AVG Volume (30 Days)
  • PRPO 17.7K
  • SFHG 50.8K
  • Earning Date
  • PRPO 08-12-2025
  • SFHG 07-22-2025
  • Dividend Yield
  • PRPO N/A
  • SFHG N/A
  • EPS Growth
  • PRPO N/A
  • SFHG N/A
  • EPS
  • PRPO N/A
  • SFHG N/A
  • Revenue
  • PRPO $20,029,000.00
  • SFHG $19,760,935.00
  • Revenue This Year
  • PRPO N/A
  • SFHG N/A
  • Revenue Next Year
  • PRPO N/A
  • SFHG N/A
  • P/E Ratio
  • PRPO N/A
  • SFHG N/A
  • Revenue Growth
  • PRPO 26.67
  • SFHG 30.89
  • 52 Week Low
  • PRPO $3.90
  • SFHG $0.55
  • 52 Week High
  • PRPO $16.89
  • SFHG $24.00
  • Technical
  • Relative Strength Index (RSI)
  • PRPO 68.17
  • SFHG N/A
  • Support Level
  • PRPO $14.25
  • SFHG N/A
  • Resistance Level
  • PRPO $16.89
  • SFHG N/A
  • Average True Range (ATR)
  • PRPO 1.08
  • SFHG 0.00
  • MACD
  • PRPO 0.24
  • SFHG 0.00
  • Stochastic Oscillator
  • PRPO 67.57
  • SFHG 0.00

About PRPO Precipio Inc.

Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents, and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.

About SFHG Samfine Creation Holdings Group Limited Ordinary Share

Samfine Creation Holdings Group Ltd operates through its subsidiaries. It is an established one-stop printing service provider which principally provides printing services in Hong Kong and the PRC. It offers a wide range of printed products such as (i) book products, which mainly include children's books, educational books, art books, notebooks, diaries and journals; and (ii) novelty and packaging products, which mainly include handcraft products, book sets, pop-up books, stationery products, products with assembly parts and other specialized products, shopping bags and package boxes.

Share on Social Networks: